Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
Andrea Romigi, Giuseppe Vitrani, Temistocle Lo Giudice, et al.
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 2665-2675
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
Yves Dauvilliers, Isabelle Arnulf, Zoltán Szakács, et al.
SLEEP (2019) Vol. 42, Iss. 11
Open Access | Times Cited: 230
Recently Approved and Upcoming Treatments for Narcolepsy
Michael J. Thorpy
CNS Drugs (2020) Vol. 34, Iss. 1, pp. 9-27
Open Access | Times Cited: 96
Update on Persistent Excessive Daytime Sleepiness in OSA
Sogol Javaheri, Shahrokh Javaheri
CHEST Journal (2020) Vol. 158, Iss. 2, pp. 776-786
Closed Access | Times Cited: 91
Expert Opinion: Managing sleep disturbances in people with epilepsy
Lino Nobili, Sándor Beniczky, Sofia Eriksson, et al.
Epilepsy & Behavior (2021) Vol. 124, pp. 108341-108341
Open Access | Times Cited: 42
Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder
Mera Alhusaini, Nermin Eissa, Ali Saad, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Search for new multi-target compounds against Alzheimer’s disease among histamine H3 receptor ligands
Marek Bajda, Dorota Łażewska, Justyna Godyń, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111785-111785
Closed Access | Times Cited: 33
Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update
Andrea Romigi, Tiziana Feola, S. Cappellano, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 16
Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)
Cinzia Volonté, Savina Apolloni, Mario Sabatelli
Pharmacology & Therapeutics (2019) Vol. 202, pp. 120-131
Open Access | Times Cited: 24
pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
Noeen Sarfraz, David Okuampa, Hannah Hansen, et al.
Health psychology research (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 13
Pitolisant nanofibers: A promising frontier in drug delivery for narcolepsy - Formulation, optimisation, and characterization insights
J. Nandhini, Karthikeyan Elumalai, C. Jegatheshwaran, et al.
Biomedical Technology (2023) Vol. 6, pp. 9-16
Open Access | Times Cited: 7
Pitolisant for treating patients with narcolepsy
Shuang Li, Junyi Yang
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 2, pp. 79-84
Closed Access | Times Cited: 16
Body Weight and Metabolic Rate Changes in Narcolepsy: Current Knowledge and Future Directions
Hamza O. Dhafar, Ahmed S. BaHammam
Metabolites (2022) Vol. 12, Iss. 11, pp. 1120-1120
Open Access | Times Cited: 10
An evaluation of sodium oxybate as a treatment option for narcolepsy
Vivien C. Abad
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 10, pp. 1189-1199
Closed Access | Times Cited: 17
Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know
Lois E. Krahn, Phyllis C. Zee, Michael J. Thorpy
Advances in Therapy (2021) Vol. 39, Iss. 1, pp. 221-243
Open Access | Times Cited: 14
Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation
Ramakrishna Nirogi, Vijay Benade, Saivishal Daripelli, et al.
Psychopharmacology (2021) Vol. 238, Iss. 6, pp. 1495-1511
Closed Access | Times Cited: 13
Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy
Junyi Yang, Junfa Gao
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 8, pp. 723-728
Closed Access | Times Cited: 15
Impact of Real-World Data on Market Authorization, Reimbursement Decision & Price Negotiation
Alfredo Pulini, Gabriela Caetano, Henri Clautiaux, et al.
Therapeutic Innovation & Regulatory Science (2020) Vol. 55, Iss. 1, pp. 228-238
Closed Access | Times Cited: 14
New pharmacologic agents for insomnia and hypersomnia
David C. Earl, Kendall M. Van Tyle
Current Opinion in Pulmonary Medicine (2020) Vol. 26, Iss. 6, pp. 629-633
Closed Access | Times Cited: 13
Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials
Yuichi Inoue, Makoto Uchiyama, Hideo Umeuchi, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Exploring the Intersection of Narcolepsy and Attention Deficit Hyperactivity Disorder: Similarities, Differences, and Clinical Implications
Sung Hoon Yoon, Young-Chan Kim, Ho‐Jun Seo, et al.
Sleep Medicine Research (2024) Vol. 15, Iss. 1, pp. 6-11
Open Access | Times Cited: 1
Basics of sleep–wake physiology for athletes and sports professionals
Kathryn Kennedy, Sadia Ghani, Brooke Mason, et al.
Elsevier eBooks (2024), pp. 1-27
Closed Access | Times Cited: 1
Aspectos sobre diagnóstico e tratamento da sonolência diurna excessiva: uma revisão sistemática
Ana Carolina Oliveira Veras, Marcela Goreske Leite, Mariane Vargas Freitas, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 4, pp. e71254-e71254
Open Access | Times Cited: 1
New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2019
Anaïs Rameau, Robert Hong, Hamid R. Djalilian, et al.
OTO Open (2020) Vol. 4, Iss. 2
Open Access | Times Cited: 11
Evaluating pitolisant as a narcolepsy treatment option
Stefano de Biase, Gaia Pellitteri, Gian Luigi Gigli, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 22, Iss. 2, pp. 155-162
Closed Access | Times Cited: 11
Bioluminescence Resonance Energy Transfer Based G Protein-Activation Assay to Probe Duration of Antagonism at the Histamine H3 Receptor
Tamara A. M. Mocking, Maurice C. M. L. Buzink, Rob Leurs, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 15, pp. 3724-3724
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top